Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Repopulation of ovarian cancer cells after chemotherapy.

Telleria CM.

Cancer Growth Metastasis. 2013 Feb 18;6:15-21.

2.

Optimal chemotherapy treatment for women with recurrent ovarian cancer.

Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P.

Curr Oncol. 2007 Oct;14(5):195-208.

3.

Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy.

Gamarra-Luques CD, Goyeneche AA, Hapon MB, Telleria CM.

BMC Cancer. 2012 Jun 22;12:200. doi: 10.1186/1471-2407-12-200.

4.

Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): a multicenter randomised controlled study.

van de Laar R, Zusterzeel PL, Van Gorp T, Buist MR, van Driel WJ, Gaarenstroom KN, Arts HJ, van Huisseling JC, Hermans RH, Pijnenborg JM, Schutter EM, Pelikan HM, Vollebergh JH, Engelen MJ, Inthout J, Kruitwagen RF, Massuger LF.

BMC Cancer. 2014 Jan 14;14:22. doi: 10.1186/1471-2407-14-22.

5.

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):340-60. Review.

PMID:
11441940
6.

Ovarian cancer, Part II: Treatment.

Ozols RF.

Curr Probl Cancer. 1992 Mar-Apr;16(2):61-126. Review.

PMID:
1617996
7.

Medical therapy of advanced malignant epithelial tumours of the ovary.

Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.

Forum (Genova). 2000 Oct-Dec;10(4):323-32. Review.

PMID:
11535983
8.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
9.

Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study.

Rochet N, Kieser M, Sterzing F, Krause S, Lindel K, Harms W, Eichbaum MH, Schneeweiss A, Sohn C, Debus J.

BMC Cancer. 2011 Jan 28;11:41. doi: 10.1186/1471-2407-11-41.

10.

Effects of sustained and intermittent paclitaxel therapy on tumor repopulation in ovarian cancer.

Vassileva V, Allen CJ, Piquette-Miller M.

Mol Cancer Ther. 2008 Mar;7(3):630-7. doi: 10.1158/1535-7163.MCT-07-2117.

11.

Tumor dormancy: long-term survival in a hostile environment.

Quesnel B.

Adv Exp Med Biol. 2013;734:181-200. doi: 10.1007/978-1-4614-1445-2_9.

PMID:
23143980
12.

Mifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatment.

Freeburg EM, Goyeneche AA, Telleria CM.

Int J Oncol. 2009 Mar;34(3):743-55.

13.

Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer.

Douwes F, BogoviC J, Douwes O, Migeod F, Grote C.

Int J Clin Oncol. 2004 Apr;9(2):85-91.

PMID:
15108039
14.

Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer.

Lim MC, Song YJ, Seo SS, Yoo CW, Kang S, Park SY.

Onkologie. 2010;33(6):324-30. doi: 10.1159/000313823. Epub 2010 May 14. Review.

PMID:
20523098
15.

In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.

Federico M, Alberts DS, Garcia DJ, Emerson J, Fanta P, Liu R, Salmon SE.

Gynecol Oncol. 1994 Dec;55(3 Pt 2):S156-63.

PMID:
7835801
16.

Gynecological malignancies.

Schaebler DL, Schilder RJ, Young RC.

Cancer Chemother Biol Response Modif. 1996;16:564-91. Review.

PMID:
8639401
17.

Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.

Matsumoto A, Higuchi T, Yura S, Mandai M, Kariya M, Takakura K, Fujii S.

J Obstet Gynaecol Res. 2006 Dec;32(6):580-7.

PMID:
17100820
18.

Emerging therapeutic options for platinum-sensitive ovarian cancer patients.

Armstrong DK, Coleman RL, Penson RT.

Clin Adv Hematol Oncol. 2011 Apr;9(4 Suppl 5):1-16. Review.

PMID:
21558997
19.

[Treatment of recurrent ovarian cancer--a retrospective study].

Tkácová M, Belohorská B, Sevcíková K, Hel'pianska L, Ondrus D, Ondrusová M, Spánik S.

Klin Onkol. 2010;23(2):115-23. Slovak.

PMID:
20465091
20.

Ovarian cancer: a brief historical overview of intraperitoneal trials.

Kwa M, Muggia F.

Ann Surg Oncol. 2014 May;21(5):1429-34. doi: 10.1245/s10434-013-3219-8. Epub 2013 Oct 1.

PMID:
24081795

Supplemental Content

Support Center